Li X - Search Results

1

Integrating systematic pharmacology-based strategy and experimental validation to explore mechanism of Tripterygium glycoside on cholangiocyte-related liver injury.

Li Y, Li S, Xue X, Wang T, Li X. Li Y, et al. Among authors: li s, li x. Chin Herb Med. 2022 Sep 27;14(4):563-575. doi: 10.1016/j.chmed.2022.02.006. eCollection 2022 Oct. Chin Herb Med. 2022. PMID: 36405068 Free PMC article.

2

Human antigen R: A potential therapeutic target for liver diseases.

Liu R, Wu K, Li Y, Sun R, Li X. Liu R, et al. Among authors: li y, li x. Pharmacol Res. 2020 May;155:104684. doi: 10.1016/j.phrs.2020.104684. Epub 2020 Feb 8. Pharmacol Res. 2020. PMID: 32045667 Review.

3

Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases.

Li Y, Liu R, Wu J, Li X. Li Y, et al. Among authors: li x. Theranostics. 2020 Jun 29;10(18):7993-8017. doi: 10.7150/thno.47826. eCollection 2020. Theranostics. 2020. PMID: 32724454 Free PMC article. Review.

4

Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases.

Wu J, Huang G, Li Y, Li X. Wu J, et al. Among authors: li y, li x. Chin Med. 2020 Aug 26;15:89. doi: 10.1186/s13020-020-00371-5. eCollection 2020. Chin Med. 2020. PMID: 32863858 Free PMC article. Review.

5

Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases.

Ma BN, Li XJ. Ma BN, et al. Chin Herb Med. 2020 Oct;12(4):349-358. doi: 10.1016/j.chmed.2020.07.003. Epub 2020 Sep 18. Chin Herb Med. 2020. PMID: 32963508 Free PMC article. Review.

6

Si-Ni-San ameliorates chronic colitis by modulating type I interferons-mediated inflammation.

Cai Y, Xu B, Zhou F, Wu J, Li S, Zheng Q, Li Y, Li X, Gao F, Dong S, Liu R. Cai Y, et al. Among authors: li s, li y, li x. Phytomedicine. 2021 Apr;84:153495. doi: 10.1016/j.phymed.2021.153495. Epub 2021 Feb 10. Phytomedicine. 2021. PMID: 33611210

7

Mechanisms exploration of Angelicae Sinensis Radix and Ligusticum Chuanxiong Rhizoma herb-pair for liver fibrosis prevention based on network pharmacology and experimental pharmacologylogy.

Wu JZ, Li YJ, Huang GR, Xu B, Zhou F, Liu RP, Gao F, Ge JD, Cai YJ, Zheng Q, Li XJ. Wu JZ, et al. Chin J Nat Med. 2021 Apr;19(4):241-254. doi: 10.1016/S1875-5364(21)60026-2. Chin J Nat Med. 2021. PMID: 33875165

8

Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation.

Wu J, Xue X, Fan G, Gu Y, Zhou F, Zheng Q, Liu R, Li Y, Ma B, Li S, Huang G, Ma L, Li X. Wu J, et al. Among authors: li s, li y, li x. Front Pharmacol. 2021 Sep 8;12:754976. doi: 10.3389/fphar.2021.754976. eCollection 2021. Front Pharmacol. 2021. PMID: 34566665 Free PMC article.

9

Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis.

Xue X, Wu J, Ding M, Gao F, Zhou F, Xu B, Lu M, Li J, Li X. Xue X, et al. Among authors: li j, li x. Chin Med. 2021 Nov 4;16(1):112. doi: 10.1186/s13020-021-00524-0. Chin Med. 2021. PMID: 34736501 Free PMC article.

10

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease.

Li X, Ge J, Li Y, Cai Y, Zheng Q, Huang N, Gu Y, Han Q, Li Y, Sun R, Liu R. Li X, et al. Among authors: li y. Acta Pharm Sin B. 2021 Nov;11(11):3527-3541. doi: 10.1016/j.apsb.2021.03.018. Epub 2021 Mar 11. Acta Pharm Sin B. 2021. PMID: 34900534 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183,579 results

Search Page

Filters